Cargando…

Entecavir: A Review and Considerations for Its Application in Oncology

Entecavir (ETV) is a drug used as a first-line treatment for chronic hepatitis B (CHB) virus infection because it is a guanosine nucleoside analogue with activity against the hepatitis B virus polymerase. The ETV dosage can range from 0.5 mg to 1 mg once a day and the most common side effects includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Lourenço, Tânia, Vale, Nuno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675314/
https://www.ncbi.nlm.nih.gov/pubmed/38004468
http://dx.doi.org/10.3390/ph16111603